Governance Evotec SE

EVT

DE0005664809

Biotechnology & Medical Research

Real-time Estimate Tradegate Other stock markets 05:49:14 09/03/2026 pm IST			5-day change	1st Jan Change
5.243 ^EUR	-2.94%		-7.84%	-3.85%

24/02	Centauri Therapeutics Limited announced that it has received £30 million in funding from a group of investors	CI
03/02	Evotec Shares Surge Following Berenberg Buy Recommendation	DP

Executive Committee: Evotec SE

Manager

Positions heldSince

Christian Wojczewski

55 year

Chief Executive Officer

01/07/2024

Cord Dohrmann

62 year

Chief Tech/Sci/R&D Officer

01/09/2010

Aurélie Dalbiez

49 year

Human Resources Officer

15/06/2024

Paul Robert Hitchin

50 year

Director of Finance/CFO

01/03/2025

Sarah Fakih

Investor Relations Contact	01/01/2026
Public Communications Contact	01/01/2026

Composition of the Board of Directors: Evotec SE

Director

CommitteesSince

Iris Löw-Friedrich

65 year

Compensation Committee Chair	15/06/2021
Nominating Committee Chair	15/06/2021

Constanze Ulmer-Eilfort

64 year

Audit Committee	01/06/2021
Compensation Committee	21/06/2023
Governance Committee	21/06/2023
Nominating Committee	21/06/2023

Camilla Languille

43 year

Audit Committee	22/06/2022
Compensation Committee	01/09/2024
HR Committee	01/09/2024

Roland Sackers

58 year

Compensation Committee	19/06/2019
Nominating Committee	19/06/2019
Audit Committee Chair	19/06/2019

Wesley Wheeler

70 year

Director/Board Member	10/06/2024
Independent Dir/Board Member	10/06/2024

Duncan McHale

59 year

Director/Board Member

10/06/2024

Latest Appointments: Evotec SE

02/01	Evotec SE Announces Executive Changes	CI
03/25/03	Evotec SE Approves Board Appointments	CI
10/25/10	Sernova Biotherapeutics Taps Pericles Calias as Chief Development Officer, R&D Head	MT
26/25/26	Evotec Names Paul Hitchin as Chief Financial Officer	MT
26/25/26	Evotec's Finance Chief to Step Down; Successor Named	MT
26/25/26	Evotec CFO Rouxel leaves - successor Mediq CFO Hitchin	DP
26/25/26	Evotec Announces CFO Change	RE

More news

Former Officers and Directors: Evotec SE

Insider

Positions held

SinceUntil

Volker Braun

Investor Relations Contact

01/01/2026

Laetitia Rouxel

Director of Finance/CFO	01/04/2023	28/02/2025
Corporate Officer/Principal	07/02/2023	01/04/2023

Hinnerk Rohwedder

Public Communications Contact

01/01/2021

01/01/2025

Craig Johnstone

Chief Operating Officer	01/01/2019	31/12/2024
Corporate Officer/Principal	01/05/2012	-

Matthias Evers

Corporate Officer/Principal

01/05/2022

01/10/2024

Elaine Sullivan

Director/Board Member

09/06/2015

10/06/2024

Bernd Mühlenweg

Corporate Officer/Principal

01/11/2022

01/06/2024

Werner Lanthaler

Chief Executive Officer	06/03/2009	03/01/2024
Investor Relations Contact	06/03/2009	-
Public Communications Contact	06/03/2009	-

Karen Lackey

Private Equity Analyst

01/06/2019

01/06/2023

Enno Spillner

Director of Finance/CFO

18/07/2016

01/03/2023

Kasim Kutay

Director/Board Member

22/06/2022

Wolfgang Plischke

Chairman	17/06/2014	15/06/2021
Independent Dir/Board Member	17/06/2014	15/06/2021

Mario Polywka

Chief Operating Officer	01/03/2004	31/12/2018
Director/Board Member	19/06/2019	10/06/2024
Chief Executive Officer	03/01/2024	01/07/2024

Leesa Gentry

Corporate Officer/Principal

01/11/2005

01/12/2018

Michael Shalmi

Director/Board Member

14/06/2017

Paul Herrling

Director/Board Member	17/06/2014	14/06/2017
Independent Dir/Board Member	17/06/2014	14/06/2017

Colin Michael Bond

Director of Finance/CFO

13/08/2010

30/06/2016

Monika Conradt

Human Resources Officer

01/06/2016

Walter Wenninger

Director/Board Member	17/06/2014	09/06/2015
Chairman	27/06/2013	17/06/2014

Andreas Pinkwart

Director/Board Member

16/06/2011

17/06/2014

Roland Oetker

Director/Board Member

16/06/2011

17/06/2014

Mary C. Tanner

Director/Board Member

04/05/2010

17/06/2014

Bernd Hirsch

Director/Board Member	16/12/2013	-
Independent Dir/Board Member	16/12/2013	-

Claus Tycho Bræstrup

Director/Board Member	12/06/2013	-
Independent Dir/Board Member	12/06/2013	-

Peter John Fellner

Director/Board Member

17/08/2009

16/06/2011

Corey Goodman

Director/Board Member

01/01/2010

Cony D’Cruz

Corporate Officer/Principal

01/01/2001

01/01/2010

Jeffrey Farrow

Director of Finance/CFO

01/05/2008

01/01/2010

Charmion Gillmore

Human Resources Officer	-	31/05/2009
Public Communications Contact	-	31/05/2009

Tim Tasker

Chief Tech/Sci/R&D Officer

30/04/2009

Jörn Aldag

Chief Executive Officer	01/11/1997	31/12/2008
President	01/11/1997	31/12/2008

Flemming Ørnskov

Director/Board Member	15/09/2009	04/05/2010
Chairman	04/05/2010	-

Heinz Riesenhuber

Chairman

01/08/2008

William John Jenkins

Director/Board Member

01/01/2008

Peer Schatz

Director/Board Member

01/01/2008

Klaus Maleck

Director of Finance/CFO	01/04/2007	13/08/2010
Corporate Officer/Principal	13/08/2010	-

Dirk H. Ehlers

Director/Board Member	01/01/2001	01/01/2007
Director of Finance/CFO	01/01/2001	01/01/2007

Hubert Birner

Director/Board Member

01/06/2005

Timm H. Jessen

Chief Operating Officer	01/11/1997	01/06/2004
Chief Tech/Sci/R&D Officer	01/11/1997	01/06/2004

Rodney Weldon Turner

Corporate Officer/Principal

01/01/1995

01/01/2001

Manfred Eigen

Director/Board Member	08/06/1998	08/06/1998
Founder	08/12/1993	08/06/1998

Ulrich Aldag

Founder	08/12/1993	28/02/1998
Corporate Officer/Principal	28/02/1998	28/02/1998

Mark Richard Ashton

Corporate Officer/Principal

01/01/1995

Karsten Henco

Founder	08/12/1993	-
President	08/12/1993	-

Charles Weissmann

Founder

08/12/1993

Rudolf Rigler

Founder

08/12/1993

Heinrich Maria Schulte

Founder

08/12/1993

Freimut Leidenberger

Director/Board Member	08/12/1993	-
Founder	08/12/1993	-

Jürgen Kupper

Corporate Officer/Principal

Mark Winderlich

Corporate Officer/Principal

Andrew Cross

Sales & Marketing

Erich Greiner

Corporate Officer/Principal

Dirk Plaga

Corporate Officer/Principal

Thomas Hanke

Director/Board Member

Dirk Ullmann

Corporate Officer/Principal

Baker Mckenzie

Director/Board Member

Edwin Moses

Director/Board Member

John Walker

Director/Board Member

Sean Marett

Corporate Officer/Principal

Jesper Paul Fredrik Wiklund

Corporate Officer/Principal

Doris Kynast

Investor Relations Contact	-	-
Public Communications Contact	04/05/2010	-

Robert Phelps

Corporate Officer/Principal

Mohammad Yaqoob

Corporate Officer/Principal

Ian M. Hunneyball

Chief Tech/Sci/R&D Officer

Gordon J. Woodrow

Corporate Officer/Principal

Phillip James Boyd

Director of Finance/CFO

Peter Seufer-Wasserthal

Corporate Officer/Principal

Adrian Howd

Corporate Officer/Principal

John A. Kemp

Chief Tech/Sci/R&D Officer

David Brister

Corporate Officer/Principal

Gabriele Hansen

Public Communications Contact	-	-
Sales & Marketing	-	-

Kam Dhaliwal

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	9
Female	2

Of which Executive Committee

Male	4
Female	1

Of which Directors

Male	5
Female	1

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, womenâ€™s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Employees

4,788

Sector

Biotechnology & Medical Research

More about the company